The Brain Mechanisms Underlying Apathy in Patients withSchizophrenia – a PET study
- Conditions
- schizophreniaapathy
- Registration Number
- NL-OMON21681
- Lead Sponsor
- MCG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patients with schizophrenia (N=20):
- At least 18 years of age
Exclusion Criteria
Patients with schizophrenia (N=20):
Use of medication that can influence task results (e.g. beta-blockers, insulin) with the
exception of antipsychotics
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Binding potential for [11C]-raclopride.
- Secondary Outcome Measures
Name Time Method endpoint<br /><br>MRI-scan<br /><br>PET-scan<br /><br>AES-C<br /><br>MINI-plus<br /><br>CDSS<br /><br>SANS<br /><br>AES-S<br /><br>SHAPS<br /><br>TEPS<br /><br>TCI<br /><br>FT<br /><br>N-back